Certified Quality & 2-Year Warranty: This diagnostic kit holds authoritative CE and ISO 13485 certifications, ensuring strict compliance with international medical standards, and comes backed by a dependable 2-year long-term product warranty.
Advanced Fluorescence Technology: Utilizing high-sensitivity time-resolved immunofluorescence chromatography (TRFIA), the reader system delivers precise, quantitative data for cardiovascular risk assessment within 15 minutes, entirely eliminating human visual misreading.
Product Introduction Copy (Marketing Copy)
【Alerting the "Hidden Bomb" of Cardiovascular Diseases - A Precise Monitoring Solution for Plaque Stability】
Myeloperoxidase (MPO) is widely recognized by the medical community as an "advanced indicator" for cardiovascular risk assessment. (Guogao Biotech) The MPO Assay Kit uses a highly sensitive fluorescence immunochromatographic technique (FIA) to identify patients who have vascular inflammation and plaque rupture risks even though traditional indicators (such as Troponin or CRP) are within the normal range.
Core Strengths
ACS Early Warning: MPO significantly increases before the onset of acute coronary syndrome (ACS), and is a key indicator for assessing the risk of unstable plaque detachment, providing precious time for clinical rescue.
Assessing the severity of inflammation: Compared to conventional inflammatory indicators, MPO is more specific to blood vessels and can directly reflect the local inflammatory response in the coronary arteries.
High-sensitivity Fluorescence Quantification: Fluorescence immunoassay chromatography ensures the sensitivity and repeatability of the test, providing doctors with precise numerical references for dynamic monitoring of the patient's condition.
Whole blood samples, ready at the bedside: Compatible with whole blood, serum, and plasma, no large laboratory equipment is required. A quantitative report can be issued within 15 minutes, suitable for emergency departments, cardiology departments, and health checkup centers.
Excellence Quality Certification: Produced by Guohao Biotechnology, strictly following international IVD standards, the quality is reliable, the operation is simple, and it effectively reduces the risk of manual misreading.
Product Specifications
| Brand | Guogao Biotech |
| Product Name | Myeloperoxidase (MPO) Assay Kit |
| Methodology | Fluorescence Immunochromatography |
| Test Type | Quantitative Determination |
| Clinical Use | Risk prediction of Acute Coronary Syndrome (ACS); Assessment of atherosclerotic plaque stability |
| Specimen | Serum / Plasma / Whole Blood |
| Reaction Time | 10 – 15 minutes |
| Linear Range | Typically 20.0 – 1000.0 ng/mL (Refer to the package insert for exact values) |
| Storage Condition | 2°C – 30°C (Store in a cool, dry place away from light) |
| Shelf Life | 24 months |
| Packaging | 25 tests/kit |
| Required Equipment | Compatible with a dedicated fluorescence immunoanalyzer for result reading |
Place of Origin: |
China,Hebei |
Brand Name: |
GuoGao |
Model Number: |
MPO |
Certification: |
CE ISO13485 |
The Hospital Lab Medical Grade Glycated Hemoglobin MPO Assay Kit Immunofluorescence Diagnostic With Reader System Rapid Test Kits is a cutting-edge, dual-biomarker Point-of-Care Testing (POCT) solution designed for modern healthcare facilities. Manufactured by Beijing Jiachuang Jiuhe Global Trade Co., Ltd, this premium Immunofluorescence Diagnostic Kit provides simultaneous, quantitative detection of Glycated Hemoglobin (HbA1c) and Myeloperoxidase (MPO). By combining a high-affinity Glycated Hemoglobin MPO Assay Kit with an advanced fluorescence Reader System, clinical laboratories and hospital ICU departments can rapidly assess long-term glycemic control alongside acute cardiovascular inflammation, significantly accelerating diagnostic workflows and improving patient outcomes.
In modern clinical diagnostics, speed and precision save lives. This Hospital Lab Diagnostic System bridges the gap between chronic disease management and acute coronary syndrome (ACS) risk stratification.
The Glycated Hemoglobin MPO Assay Kit utilizes advanced time-resolved immunofluorescence chromatography. When a patient sample is applied, the specific antigens bind with fluorescent-labeled antibodies on the test strip. The accompanying Fluorescence Immunoassay Reader scans the emission intensity, translating it into precise quantitative data within minutes.
While HbA1c remains the gold standard for monitoring diabetes mellitus over a 3-month cycle, Myeloperoxidase (MPO) serves as a critical neutrophil-activation marker that predicts plaque vulnerability and acute myocardial infarction (AMI) risks. Integrating these two tests into one medical-grade Immunofluorescence Diagnostic Kit system allows clinicians to screen diabetic patients for underlying macrovascular complications seamlessly. This eliminates the need for bulky, time-consuming central laboratory equipment, optimizing the operational efficiency of Hospital Lab Medical Grade Rapid Test Kits.
Dual-Biomarker Synergy: Measures both metabolic control (HbA1c) and vascular inflammation (MPO) in one comprehensive Hospital Lab Diagnostic System.
Advanced Fluorescence Reader System: High-resolution optical sensors deliver precise, objective quantification, eliminating human visual error.
Rapid Turnaround Time: Delivers lab-quality quantitative results within 3–15 minutes, making it ideal for emergency rooms and intensive care units.
Minimal Sample Volume: Requires only a tiny fingerstick or whole blood sample, reducing patient discomfort during Diabetes Point of Care Testing.
Robust Calibration & Stability: Built-in RFID chip calibration ensures batch-to-batch consistency for the Glycated Hemoglobin MPO Assay Kit.
The core strength of this Immunofluorescence Diagnostic Kit lies in its sub-nanogram sensitivity. Traditional colloidal gold rapid tests only offer qualitative or semi-quantitative results. In contrast, our Hospital Lab Medical Grade Rapid Test Kits leverage rare-earth nanocrystals that feature large Stokes shifts and long emission lifetimes.
Clinical research indicates that chronic hyperglycemia alters vascular endothelium, accelerating atherosclerosis. By deploying this HbA1c MPO POCT Analyzer, cardiologists and endocrinologists can detect microvascular inflammation early. MPO acts as an early-stage warning signal for neutrophil activation in vulnerable plaques before actual myocardial necrosis occurs. Thus, utilizing this comprehensive Glycated Hemoglobin MPO Assay Kit elevates standard patient care from reactive treatment to proactive risk mitigation.
| Parameter | Specifications & Details |
| Product Name | Hospital Lab Medical Grade Glycated Hemoglobin MPO Assay Kit |
| Testing Methodology | Time-Resolved Immunofluorescence Immunoassay (TRFIA) |
| Compatible Equipment | Specialized Fluorescence Immunoassay Reader System |
| Sample Type | Whole Blood, Serum, or Plasma |
| HbA1c Detection Range | 4.0% – 15.0% |
| MPO Detection Range | 20 ng/mL – 1000 ng/mL |
| Reaction/Test Time | ≤ 15 Minutes |
| Storage Temperature | 4°C – 30°C (Shelf life: 24 months) |
| Manufacturer | Beijing Jiachuang Jiuhe Global Trade Co., Ltd |
Hospital Central Labs & ICUs: Enables rapid screening for patients presenting with chest pains or acute metabolic distress.
Endocrinology Clinics: Streamlines routine Diabetes Point of Care Testing while simultaneously screening for cardiovascular co-morbidities.
Cardiology Departments: Facilitates rapid Cardiovascular Risk Rapid Test protocols to assess vulnerable arterial plaques.
Community Health Centers: Brings affordable, high-tier Medical Grade Rapid Test Kits to decentralized healthcare networks.
For medical distributors, hospital procurement officers, and laboratory directors, investing in the Hospital Lab Diagnostic System from Beijing Jiachuang Jiuhe Global Trade Co., Ltd yields excellent returns.
Reduced Overhead Costs: Consolidating multiple parameters onto a single Immunofluorescence Diagnostic Kit platform lowers inventory maintenance costs and reduces plastic waste.
High Throughput & Patient Turnaround: Rapid processing means clinics can see more patients per day, increasing revenue.
Regulatory Compliance & Trust: Manufactured under strict ISO 13485 guidelines, ensuring international customs compliance and rapid registration in global markets.
No. To get precise, quantitative medical-grade results, the test cassettes must be read using our matching Fluorescence Immunoassay Reader.
Our kits are stable for up to 24 months when stored at room temperature (4°C–30°C). Do not freeze the test strips.
Diabetes significantly increases cardiovascular risks. Testing with an HbA1c MPO POCT Analyzer allows physicians to evaluate both blood sugar stability and active vascular inflammation at the same time, preventing heart attacks before they happen.
Certified Quality & 2-Year Warranty: This diagnostic kit holds authoritative CE and ISO 13485 certifications, ensuring strict compliance with international medical standards, and comes backed by a dependable 2-year long-term product warranty.
Advanced Fluorescence Technology: Utilizing high-sensitivity time-resolved immunofluorescence chromatography (TRFIA), the reader system delivers precise, quantitative data for cardiovascular risk assessment within 15 minutes, entirely eliminating human visual misreading.
EN